Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Ironwood Pharmaceuticals Inc shares valued at $162,914 were sold by Silver Ronald on Jan 05 ’26. At $4.60 per share, Silver Ronald sold 35,416 shares. The insider’s holdings dropped to 276,809 shares worth approximately $1.1 million following the completion of this transaction.
Also, RONALD SILVER purchased 35,416 shares, netting a total of over 151,226 in proceeds.
Before that, Gaskins Tammi L had sold 6,016 shares from its account. In a trade valued at $19,973, the Chief Commercial Officer traded Ironwood Pharmaceuticals Inc shares for $3.32 each. Upon closing the transaction, the insider’s holdings decreased to 6,016 shares, worth approximately $0.94 million.
As published in a research note from Citizens JMP on January 05, 2026, Ironwood Pharmaceuticals Inc [IRWD] has been rated up from a Mkt perform to a Mkt outperform and the price target has been revised to $8. Analysts at Wells Fargo downgraded the stock from ‘”an Overweight”‘ to ‘”an Equal weight”‘ outlook in a report released in mid April. As of April 15, 2025, Jefferies has decreased its “Buy” rating to a “Hold” for IRWD. Earlier on April 14, 2025, Citizens JMP downgraded its rating. Their new recommendation was “a Mkt perform” for IRWD stock which previously was a “a Mkt outperform”.
Analyzing IRWD Stock Performance
On last trading session, Ironwood Pharmaceuticals Inc [NASDAQ: IRWD] plunged -2.45% to $3.98. The stock’s lowest price that day was $3.94, but it reached a high of $4.1295 in the same session. During the last five days, there has been a surge of approximately 18.10%. Over the course of the year, Ironwood Pharmaceuticals Inc shares have dropped approximately -11.56%. Shares of the company reached a 52-week high of $5.78 on 01/02/26 and a 52-week low of $3.94 on 01/08/26.
Support And Resistance Levels for Ironwood Pharmaceuticals Inc (IRWD)
According to the 24-hour chart, there is a support level at 3.90, which, if violated, would cause prices to drop to 3.83. In the upper region, resistance lies at 4.09. The next price resistance is at 4.21. RSI (Relative Strength Index) is 59.73 on the 14-day chart, showing neutral technical sentiment.
Is Ironwood Pharmaceuticals Inc subject to short interest?
Stocks of Ironwood Pharmaceuticals Inc saw a sharp rise in short interest on 2025-12-15 jumping by 0.17 million shares to 7.33 million. Data from Yahoo Finance shows that the short interest on 2025-11-14 was 7.15 million shares. A jump of 2.38% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 3.18 of the overall float, the days-to-cover ratio (short ratio) jumped to 3.18.
Which companies own the most shares of Ironwood Pharmaceuticals Inc (IRWD)?
In terms of Ironwood Pharmaceuticals Inc share price expectations, FactSet research, analysts set an average price target of 5.35 in the next 12 months, up nearly 31.13% from the previous closing price of $4.08. Analysts anticipate Ironwood Pharmaceuticals Inc stock to reach 5.7 by 2026, with the lowest price target being 5. In spite of this, 2 analysts ranked Ironwood Pharmaceuticals Inc stock as Buy at the end of 2026. On September 09, 2024, Leerink Partners assigned a price target of “a Market perform” to the stock and initiated coverage with a $5.
